WAVE Life Sciences Ltd.
WVE
$6.59
$0.0450.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.33M | -97.01M | -142.52M | -73.49M | -61.67M |
| Total Depreciation and Amortization | 8.65M | 8.66M | 8.69M | 8.80M | 8.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.21M | 13.14M | 12.25M | 11.00M | 9.93M |
| Change in Net Operating Assets | -92.17M | -75.82M | -19.04M | -74.91M | -95.59M |
| Cash from Operations | -180.63M | -151.03M | -140.62M | -128.60M | -138.39M |
| Capital Expenditure | -686.00K | -938.00K | -1.21M | -1.02M | -1.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -686.00K | -938.00K | -1.21M | -1.02M | -1.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 229.46M | 239.81M | 298.77M | 110.80M | 111.99M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 14.08M | 14.08M | 14.10M | -- | -- |
| Cash from Financing | 243.54M | 253.89M | 312.87M | 110.80M | 111.99M |
| Foreign Exchange rate Adjustments | -6.00K | -138.00K | 23.00K | -129.00K | -148.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.21M | 101.79M | 171.07M | -18.95M | -27.59M |